Perseus Proteomics Inc. (4882.T)

JPY 610.0

(-0.65%)

Revenue Summary of Perseus Proteomics Inc.

  • Perseus Proteomics Inc.'s latest annual revenue in 2023 was 100.4 Million JPY , up 6.58% from previous year.
  • Perseus Proteomics Inc.'s latest quarterly revenue in 2024 Q1 was 20 Million JPY , down -30.35% from previous quarter.
  • Perseus Proteomics Inc. reported a annual revenue of 94.2 Million JPY in annual revenue 2022, up 30.96% from previous year.
  • Perseus Proteomics Inc. reported a annual revenue of 71.93 Million JPY in annual revenue 2021, up 5.86% from previous year.
  • Perseus Proteomics Inc. reported a quarterly revenue of 26.16 Million JPY for 2023 Q2, up 5.59% from previous quarter.
  • Perseus Proteomics Inc. reported a quarterly revenue of 24.77 Million JPY for 2023 Q1, up 0.99% from previous quarter.

Annual Revenue Chart of Perseus Proteomics Inc. (2023 - 2019)

Historical Annual Revenue of Perseus Proteomics Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 100.4 Million JPY 6.58%
2022 94.2 Million JPY 30.96%
2021 71.93 Million JPY 5.86%
2020 67.94 Million JPY -20.06%
2019 85 Million JPY 0.0%

Peer Revenue Comparison of Perseus Proteomics Inc.

Name Revenue Revenue Difference
Kyowa Kirin Co., Ltd. 442.23 Billion JPY 99.977%
Astellas Pharma Inc. 1603.67 Billion JPY 99.994%
Chugai Pharmaceutical Co., Ltd. 1111.36 Billion JPY 99.991%
Ono Pharmaceutical Co., Ltd. 502.67 Billion JPY 99.98%
Santen Pharmaceutical Co., Ltd. 301.96 Billion JPY 99.967%
JCR Pharmaceuticals Co., Ltd. 42.87 Billion JPY 99.766%
Daiichi Sankyo Company, Limited 1601.68 Billion JPY 99.994%
Otsuka Holdings Co., Ltd. 2018.56 Billion JPY 99.995%